📚 Internal Medicine Osce Clinical Skills Renal Replacement Therapy

📚 Lecture Overview

This summary covers the primary modalities of Renal Replacement Therapy (RRT), focusing on kidney transplantation, hemodialysis, peritoneal dialysis, and advanced blood filtration methods. It details the mechanisms, indications, access methods, donor-recipient evaluation criteria, and potential clinical complications associated with each therapy. Understanding these concepts is critical for managing end-stage renal disease and acute kidney failure in clinical practice.

🎯 Key Concepts & Definitions

• Renal Replacement Therapy (RRT): Medical modalities (dialysis or transplantation) that perform essential physiological functions when a patient's own kidneys fail.
• Pre-emptive Transplantation: Kidney transplantation performed before a patient ever initiates dialysis therapy, resulting in superior long-term clinical outcomes.
• Rule of 6s (AV Fistula Maturation): Criteria defining a mature fistula: blood flow >600 mL/min, depth ≤6 mm from skin, engorged length of 6 cm, diameter ≥6 mm, and a maturation period of at least 6 weeks.
• Dialysis Disequilibrium Syndrome: A acute neurological complication caused by rapid clearance of plasma urea during initial dialysis sessions, causing an osmotic shift of water into brain tissue, cerebral edema, and seizures.
• Hemofiltration (HF): A blood purification technique using convection driven by a negative pressure gradient without dialysate, optimized for clearing high-molecular-weight toxins with high hemodynamic stability.
• Hemodiafiltration (HDF): A hybrid therapy combining diffusion (hemodialysis) and convection (hemofiltration) to clear both small and large uremic toxins.

📖 Main Content

1. Kidney Transplantation

Placement and Anatomy

• Anatomical Site: The transplanted kidney is placed extraperitoneally in the right iliac fossa, not in the original renal fossa.
• Clinical Vulnerability: Because of its superficial anatomical placement, the donor kidney is vulnerable to direct trauma. Patients must avoid contact sports (e.g., soccer) to prevent severe hematoma and graft injury.

Donor Sources & Matching

• Donor Types:
• Living Donor: Fully healthy living individual.
• Deceased Donor (Cadaveric): Brain-dead individual (not practiced in Egypt).
• Note: No artificial kidneys or xenografts (animal-to-human) are currently used.
• Matching Requirements:
• HLA Matching: Tissue typing for compatibility.
• Cross-Matching: Must be negative to confirm the recipient does not possess antibodies against donor antigens.
• Antibody Sources: Pre-formed antibodies in the recipient arise from prior blood transfusions, previous transplants, or past pregnancy.

Donor Criteria & Kidney Selection

• Living Donor Requirements:
• Age ≥18 years (medico-legal requirement); similar donor-recipient age preferred.
• Normal GFR with no proteinuria.
• Free from diabetes, cardiac/chest disease, malignancy, or recurrent kidney stones (a single past stone may be acceptable).
• Hypertension is allowed only if well-controlled on a single drug with preserved renal function.
• No active infections (Hepatitis C is a contraindication for donation in Egypt).
• Kidney Selection: A split GFR test measures individual kidney function. The donor's worse-functioning kidney is harvested, leaving the donor with their better kidney (remaining GFR must be >60 mL/min).
• Donor Risk: Donating increases long-term risks for AKI, CKD, and end-stage renal disease.

Recipient Management & Complications

• Contraindications: Active malignancy, active infection (Hepatitis C may be an exception for recipients), severe mental illness/drug abuse (non-compliance risk), and severe systemic illness (e.g., severe heart failure, severe restrictive lung disease).
• Immunosuppression Balancing Act:
• Excess Immunosuppression: High risk of opportunistic infection and malignancy.
• Inadequate Immunosuppression: High risk of organ rejection.
• Graft Loss: The single most common cause of graft loss is death of the patient with a functioning graft (frequently due to systemic infections while clinicians maintain high immunosuppression levels).

2. Dialysis Principles & Indications

Types of Dialysis

1. Hemodialysis (HD): Blood is circulated through an external dialyzer containing a semi-permeable membrane to exchange solutes with dialysate.
2. Peritoneal Dialysis (PD): Dialysate is instilled into the peritoneal cavity, utilizing the patient's peritoneum as a natural filtering membrane.

Timeline for CKD Management

• GFR < 30 mL/min (Preparation Phase): Begin patient assessment, evaluate access options (fistula/graft), and initiate donor search/workup.
• GFR < 15 mL/min (Intervention Phase): Perform surgical interventions for access creation (e.g., AV fistula placement).

Triggers for Acute/Urgent Dialysis

AKI vs. CKD Dialysis Considerations

• Tolerance: AKI patients are less tolerant of elevated urea levels and develop uremic encephalopathy at lower levels compared to CKD patients.
• Reversibility: AKI is potentially reversible; clinicians may prolong medical management to allow native recovery. CKD is irreversible, making persistent quality-of-life symptoms a strong justification to begin chronic dialysis.

3. Hemodialysis Practical Aspects

Mechanics & Transport

• Diffusion: Movement of uremic toxins (urea, creatinine) down their concentration gradient from blood into dialysate.
• Ultrafiltration: Removal of excess water driven by a negative pressure gradient across the dialyzer membrane.
• Bicarbonate Delivery: Delivered to correct acidosis; added separately from dialysate concentrate to avoid chemical precipitation.

Vascular Access Comparison

Distal Access (Wrist: Radiocephalic) ---> Proximal Access (Elbow: Brachiocephalic) ---> Upper Arm (Brachiobasilic)

• AV Fistula (Gold Standard):
• Surgical connection between an artery and a vein.
• Requires ≥6 weeks to "arterialize" (thickened walls, enlarged diameter).
• Complication: High-output heart failure. Absolute contraindication if Ejection Fraction (EF) < 30%.
• AV Graft:
• Synthetic tube connecting an artery and a vein. Used when native vessels are unsuitable.
• Usable in ~2 weeks.
• Central Venous Catheter:
• Double-lumen catheter inserted into internal jugular, subclavian, or femoral veins.
• Temporary: Standard non-tunneled catheters (femoral ~1 week; neck/chest up to 1 month). High infection risk.
• Permanent (Permacath): Tunneled under the skin for long-term use.
• Drawback: Higher blood recirculation rate, reducing overall dialysis efficiency.

Complications During Hemodialysis

• Dialysis Disequilibrium Syndrome: Rapid clearing of blood urea causes a high osmotic concentration inside brain cells relative to blood, pulling fluid into the brain.
• Prevention: Keep initial dialysis sessions short (1.5 to 2 hours) at reduced blood flow efficiency.
• Hypotension: Common result of ultrafiltration and extracorporeal blood volume shift.
• Clotting & Anticoagulation: Systemic heparin is routinely administered during sessions.
• CRITICAL EXCEPTION: Heparin is strictly contraindicated in patients with uremic pericarditis to avoid precipitating a fatal hemorrhagic pericardial effusion. Dialyze daily without heparin until pericarditis resolves.

4. Peritoneal Dialysis & Advanced Modalities

Peritoneal Dialysis (PD)

• Mechanism: Dialysate containing hypertonic glucose is instilled into the peritoneal cavity via a catheter. Glucose creates an osmotic gradient that draws excess water (ultrafiltration) and toxins (diffusion) from peritoneal capillaries into the fluid.
• Adjustability: Ultrafiltration volume is controlled by increasing the glucose concentration of the fluid.
• Modes:
• Automated PD (APD): Machine automatically performs exchanges overnight while the patient sleeps.
• Continuous Ambulatory PD (CAPD): Patient performs 3–4 manual fluid exchanges throughout the day.

Advanced Hemodialysis Techniques

• Hemofiltration (HF): Uses convection (negative pressure pulls up to 100L of water dragging high-molecular-weight solutes with it) with simultaneous fluid replacement. Uses no dialysate. Maintains superior hemodynamic stability; ideal for septic or unstable patients.
• Hemodiafiltration (HDF): Combines diffusion (clears small solutes like urea) and convection (clears large molecules). Provides superior clearance and blood pressure stability, though at higher cost.

📊 Visual Learning

Diagram 1: Vascular Access Selection Hierarchy

Diagram 2: Modalities of Renal Replacement Therapy

Diagram 3: Pathophysiology of Dialysis Disequilibrium Syndrome

💡 Important Points to Remember

• Transplant Site: Placed extraperitoneally in the right iliac fossa (superficial; no contact sports like soccer).
• Primary Graft Loss Cause: Death of the recipient with a functioning graft (often secondary to infection due to unreduced immunosuppression).
• Split GFR Protocol: The worse donor kidney is taken during live donation; the donor's remaining kidney GFR must remain >60 mL/min.
• Hyperkalemia Treatment Role: Intravenous calcium stabilizes the cardiac membrane against lethal arrhythmias but does NOT lower serum potassium levels.
• Pericarditis Heparin Rule: Heparin is strictly contraindicated during dialysis in uremic pericarditis due to the risk of hemorrhagic effusion. Use daily heparin-free hemodialysis.
• Fistula Heart Failure Risk: AV fistulas increase cardiac output and are contraindicated if the patient's EF is <30%.
• AV Fistula Rule of 6: Maturation requires >600 mL/min flow, ≤6 mm depth, 6 cm length, ≥6 mm diameter, and 6 weeks time.
• Dialysis Disequilibrium Prevention: Prevented by limiting the duration of first-time dialysis sessions to 1.5–2 hours at low clearance rates.
• Hemofiltration Mechanism: Operates via convection without dialysate; superior for septic/unstable patients needing large-molecule clearance.

⚠️ Common Exam Questions & Traps

MCQ Traps & Misconceptions

• Trap 1: Medical management of hyperkalemia
• Examiner Trick: Questions will ask which agent lowers serum potassium in an ECG-emergency setting. Options will include Calcium Gluconate.
• Correction: Calcium stabilizes the cardiac membrane; it does not lower potassium levels. Insulin/glucose, beta-agonists, and resins reduce/shift potassium levels.
• Trap 2: Dialysis protocols in uremic pericarditis
• Examiner Trick: A patient with uremic pericarditis is prescribed standard hemodialysis. You are asked to select the correct heparin dosing adjustment.
• Correction: The correct answer is Zero Heparin (Heparin-free daily dialysis). Giving heparin risks tamponade via hemorrhagic effusion.
• Trap 3: Cause of graft loss post-transplant
• Examiner Trick: Asking for the most common cause of transplant graft loss, listing chronic rejection, acute rejection, and patient death.
• Correction: The leading cause is death of the patient with a functioning graft.
• Trap 4: Transplant placement location
• Examiner Trick: Stating that failed kidneys are removed and replaced in the retroperitoneal anatomical position.
• Correction: Native kidneys are left in place; the graft is inserted superficially into the right iliac fossa.
• Trap 5: Donated kidney choice
• Examiner Trick: Claiming the best-functioning kidney is harvested to optimize recipient outcomes.
• Correction: The worse-functioning kidney is harvested to protect the living donor's health.

📝 Quick Review Checklist

I can explain why a transplanted kidney is anatomically vulnerable to physical trauma.
I know the donor selection criteria, including the split GFR rule and age constraints.
I can list the absolute triggers for urgent dialysis (hyperkalemia, acidosis, overload, uremia).
I understand why calcium is given in hyperkalemia and know that it does not lower serum potassium.
I can recall all parameters of the AV Fistula Rule of 6.
I know why heparin must be omitted in patients undergoing dialysis for uremic pericarditis.
I can describe the cause and prevention of Dialysis Disequilibrium Syndrome.
I can differentiate between Hemodialysis, Hemofiltration, and Hemodiafiltration regarding clearance mechanisms (diffusion vs. convection).